The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.
TOKYO,Feb. 13,2025-- The global energy sector is gearing up for one of the most anticipated events of the year. From February 19 to 21,2025,Ampace and TDK will jointly exhibit at Tokyo Big Sight (Boot
HO CHI MINH CITY,Vietnam,Feb. 13,2025-- XDENT LAB,one of the leading providers in the field of Removable Denture manufacturing in Vietnam,has officially announced the expansion of its production facil
VANCOUVER,BC,Feb. 13,2025-- IFS,the leading provider of enterprise cloud and Industrial AI software,announces that WEL Networks,a leading provider of innovative and sustainable energy solutions and el
PETALING JAYA,Malaysia,Feb. 14,2025-- As people live longer,ensuring a purposeful and fulfilling life becomes even more important.Life expectancy in Malaysia has steadily increased to 76.26 years ([1]
New Donner OURA™ Series of digitalpianos blends Scandinavian minimalist design high-quality sounds ANAHEIM,Calif.,Feb. 14,2025--Donner,a leader in musical instrument innovation,has officially launch
